You are on page 1of 15

Global Strategy for the Diagnosis, Management, and Prevention of COPD (2010 update) Publications Reviewed by the GOLD

Science Committee The process to produce this 2010 update included a Pub Med search for the period July 1, 2009 to June 30, 2010 using search fields established by the Committee: 1) COPD OR chronic bronchitis OR emphysema, All Fields, All Adult: 19+ years, only items with abstracts, Clinical Trial, Human; and 2) COPD OR chronic bronchitis OR emphysema AND systematic, All Fields, only items with abstracts, human. 1. Abedi NN, Davenport DL, Xenos E, Sorial E, Minion DJ, Endean ED. Gender and 30-day outcome in patients undergoing endovascular aneurysm repair (EVAR): an analysis using the ACS NSQIP dataset. J Vasc Surg 2009;50:486-91, 491 e1-4. 2. Adams SG, Anzueto A, Briggs DD, Jr., Leimer I, Kesten S. Evaluation of withdrawal of maintenance tiotropium in COPD. Respir Med 2009;103:1415-20. 3. Agapov E, Battaile JT, Tidwell R, Hachem R, Patterson GA, Pierce RA, Atkinson JJ, Holtzman MJ. Macrophage chitinase 1 stratifies chronic obstructive lung disease. Am J Respir Cell Mol Biol 2009;41:379-84. 4. Ahmed S, Bourbeau J, Maltais F, Mansour A. The Oort structural equation modeling approach detected a response shift after a COPD self-management program not detected by the Schmitt technique. J Clin Epidemiol 2009;62:1165-72. 5. Allan PF, Thomas KV, Ward MR, Harris AD, Naworol GA, Ward JA. Feasibility study of noninvasive ventilation with helium-oxygen gas flow for chronic obstructive pulmonary disease during exercise. Respir Care 2009;54:1175-82. 6. Anzueto A, Ferguson GT, Feldman G, Chinsky K, Seibert A, Emmett A, Knobil K, O'Dell D, Kalberg C, Crater G. Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes. COPD 2009;6:320-9. 7. Basanta M, Jarvis RM, Xu Y, Blackburn G, Tal-Singer R, Woodcock A, Singh D, Goodacre R, Thomas CL, Fowler SJ. Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers. Analyst;135:315-20. 8. Bastarrika G, Wisnivesky JP, Pueyo JC, Diaz L, Arraiza M, Villanueva A, Alcaide AB, Campo A, Seijo L, de Torres JP, Zulueta JJ. Low-dose volumetric computed tomography for quantification of emphysema in asymptomatic smokers participating in an early lung cancer detection trial. J Thorac Imaging 2009;24:206-11. 9. Beier J, Beeh KM, Brookman L, Peachey G, Hmissi A, Pascoe S. Bronchodilator effects of indacaterol and formoterol in patients with COPD. Pulm Pharmacol Ther 2009;22:492-6. 10. Benzo R, Farrell MH, Chang CC, Martinez FJ, Kaplan R, Reilly J, Criner G, Wise R, Make B, Luketich J, Fishman AP, Sciurba FC. Integrating health status and survival data: the palliative effect of lung volume reduction surgery. Am J Respir Crit Care Med 2009;180:239-46. 11. Bernstein JA, Davis B, Alvarez-Puebla MJ, Nguyen D, Levin L, Olaguibel JM. Is exhaled nitric oxide a useful adjunctive test for assessing asthma? J Asthma 2009;46:955-60. 12. Bertomeu V, Cordero A, Quiles J, Mazon P, Aznar J, Bueno H. Control of risk factors in and treatment of patients with coronary heart disease: the TRECE study. Rev Esp Cardiol 2009;62:807-11. 13. Bjorgen S, Helgerud J, Husby V, Steinshamn S, Richadson RR, Hoff J. Aerobic high intensity one-legged interval cycling improves peak oxygen uptake in chronic obstructive

pulmonary disease patients; no additional effect from hyperoxia. Int J Sports Med 2009;30:8728. 14. Blanco I, Gimeno E, Munoz PA, Pizarro S, Gistau C, Rodriguez-Roisin R, Roca J, Barbera JA. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med;181:270-8. 15. Blinderman CD, Homel P, Billings JA, Tennstedt S, Portenoy RK. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manage 2009;38:115-23. 16. Bon JM, Leader JK, Weissfeld JL, Coxson HO, Zheng B, Branch RA, Kondragunta V, Lee JS, Zhang Y, Choi AM, Lokshin AE, Kaminski N, Gur D, Sciurba FC. The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease. PLoS One 2009;4:e6865. 17. Borghi-Silva A, Arena R, Castello V, Simoes RP, Martins LE, Catai AM, Costa D. Aerobic exercise training improves autonomic nervous control in patients with COPD. Respir Med 2009;103:1503-10. 18. Broekhuizen BD, Sachs AP, Oostvogels R, Hoes AW, Verheij TJ, Moons KG. The diagnostic value of history and physical examination for COPD in suspected or known cases: a systematic review. Fam Pract 2009;26:260-8. 19. Brullmann G, Fritsch K, Thurnheer R, Bloch KE. Respiratory monitoring by inductive plethysmography in unrestrained subjects using position sensor-adjusted calibration. Respiration;79:112-20. 20. Bunker J, Hermiz O, Zwar N, Dennis SM, Vagholkar S, Crockett A, Marks G. Feasibility and efficacy of COPD case finding by practice nurses. Aust Fam Physician 2009;38:826-30. 21. Calbo E, Valdes E, Ochoa de Echaguen A, Fleites A, Molinos L, Xercavins M, Freixas N, Rodriguez-Carballeira M, Garau J. Bacteraemic pneumococcal pneumonia in COPD patients: better outcomes than expected. Eur J Clin Microbiol Infect Dis 2009;28:971-6. 22. Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 2009;374:685-94. 23. Cambria RP, Crawford RS, Cho JS, Bavaria J, Farber M, Lee WA, Ramaiah V, Kwolek CJ. A multicenter clinical trial of endovascular stent graft repair of acute catastrophes of the descending thoracic aorta. J Vasc Surg 2009;50:1255-64 e1-4. 24. Carr SJ, Hill K, Brooks D, Goldstein RS. Pulmonary rehabilitation after acute exacerbation of chronic obstructive pulmonary disease in patients who previously completed a pulmonary rehabilitation program. J Cardiopulm Rehabil Prev 2009;29:318-24. 25. Carrera M, Marin JM, Anton A, Chiner E, Alonso ML, Masa JF, Marrades R, Sala E, Carrizo S, Giner J, Gomez-Merino E, Teran J, Disdier C, Agusti AG, Barbe F. A controlled trial of noninvasive ventilation for chronic obstructive pulmonary disease exacerbations. J Crit Care 2009;24:473 e7-14. 26. Carrieri-Kohlman V, Donesky-Cuenco D, Park SK, Mackin L, Nguyen HQ, Paul SM. Additional evidence for the affective dimension of dyspnea in patients with COPD. Res Nurs Health;33:4-19. 27. Castaldi PJ, Cho MH, Cohn M, Langerman F, Moran S, Tarragona N, Moukhachen H, Venugopal R, Hasimja D, Kao E, Wallace B, Hersh CP, Bagade S, Bertram L, Silverman EK, Trikalinos TA. The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. Hum Mol Genet;19:526-34.

28. Celli B, Decramer M, Kesten S, Liu D, Mehra S, Tashkin DP. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;180:948-55. 29. Chae EJ, Seo JB, Song JW, Kim N, Park BW, Lee YK, Oh YM, Lee SD, Lim SY. Slope of emphysema index: an objective descriptor of regional heterogeneity of emphysema and an independent determinant of pulmonary function. AJR Am J Roentgenol;194:W248-55. 30. Chalmers JD, Singanayagam A, Murray MP, Scally C, Fawzi A, Hill AT. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with communityacquired pneumonia. Thorax 2009;64:592-7. 31. Chanez P, Burge PS, Dahl R, Creemers J, Chuchalin A, Lamarca R, Garcia Gil E. Aclidinium bromide provides long-acting bronchodilation in patients with COPD. Pulm Pharmacol Ther;23:15-21. 32. Chang HM, Lee SW, Nomura E, Tanigawa N. Laparoscopic versus open gastrectomy for gastric cancer patients with COPD. J Surg Oncol 2009;100:456-8. 33. Chapman TH, Wilde M, Sheth A, Madden BP. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use? Vascul Pharmacol 2009;51:90-5. 34. Chatterjee AB, Rissmiller RW, Meade K, Paladenech C, Conforti J, Adair NE, Haponik EF, Chin R, Jr. Reproducibility of the 6-minute walk test for ambulatory oxygen prescription. Respiration;79:121-7. 35. Chavannes NH, Grijsen M, van den Akker M, Schepers H, Nijdam M, Tiep B, Muris J. Integrated disease management improves one-year quality of life in primary care COPD patients: a controlled clinical trial. Prim Care Respir J 2009;18:171-6. 36. Chavannes NH, Schermer TR, Wouters EF, Akkermans RP, Dekhuijzen RP, Muris JW, van Weel C, van Schayck OC. Predictive value and utility of oral steroid testing for treatment of COPD in primary care: the COOPT study. Int J Chron Obstruct Pulmon Dis 2009;4:431-6. 37. Cicero TJ, Wong G, Tian Y, Lynskey M, Todorov A, Isenberg K. Co-morbidity and utilization of medical services by pain patients receiving opioid medications: data from an insurance claims database. Pain 2009;144:20-7. 38. Costi S, Crisafulli E, Antoni FD, Beneventi C, Fabbri LM, Clini EM. Effects of unsupported upper extremity exercise training in patients with COPD: a randomized clinical trial. Chest 2009;136:387-95. 39. Crim C, Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Willits LR, Yates JC, Vestbo J. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 2009;34:641-7. 40. Crisafulli E, Manni G, Kidonias M, Trianni L, Clini EM. Subjective sleep quality during average volume assured pressure support (AVAPS) ventilation in patients with hypercapnic COPD: a physiological pilot study. Lung 2009;187:299-305. 41. Dalby C, Polanowski T, Larsson T, Borgstrom L, Edsbacker S, Harrison TW. The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial. Respir Res 2009;10:104. 42. D'Angelo E, Santus P, Civitillo MF, Centanni S, Pecchiari M. Expiratory flow-limitation and heliox breathing in resting and exercising COPD patients. Respir Physiol Neurobiol 2009;169:291-6.

43. Daniels JM, Snijders D, de Graaff CS, Vlaspolder F, Jansen HM, Boersma WG. Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med;181:150-7. 44. de Almeida FG, Victor EG, Rizzo JA. Hallway versus treadmill 6-minute-walk tests in patients with chronic obstructive pulmonary disease. Respir Care 2009;54:1712-6. 45. de Hartog JJ, Ayres JG, Karakatsani A, Analitis A, Brink HT, Hameri K, Harrison R, Katsouyanni K, Kotronarou A, Kavouras I, Meddings C, Pekkanen J, Hoek G. Lung function and indicators of exposure to indoor and outdoor particulate matter among asthma and COPD patients. Occup Environ Med;67:2-10. 46. de Marco R, Accordini S, Anto JM, Gislason T, Heinrich J, Janson C, Jarvis D, Kunzli N, Leynaert B, Marcon A, Sunyer J, Svanes C, Wjst M, Burney P. Long-term outcomes in mild/moderate chronic obstructive pulmonary disease in the European community respiratory health survey. Am J Respir Crit Care Med 2009;180:956-63. 47. de Oca MM, Talamo C, Halbert RJ, Perez-Padilla R, Lopez MV, Muino A, Jardim JR, Valdivia G, Pertuze J, Moreno D, Menezes AM. Frequency of self-reported COPD exacerbation and airflow obstruction in five Latin American cities: the Proyecto Latinoamericano de Investigacion en Obstruccion Pulmonar (PLATINO) study. Chest 2009;136:71-8. 48. Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet 2009;374:1171-8. 49. Deo V, Bhongade ML, Ansari S, Chavan RS. Periodontitis as a potential risk factor for chronic obstructive pulmonary disease: a retrospective study. Indian J Dent Res 2009;20:466-70. 50. Dourado VZ, Antunes LC, Tanni SE, Godoy I. Factors associated with the minimal clinically important difference for health-related quality of life after physical conditioning in patients with COPD. J Bras Pneumol 2009;35:846-53. 51. Dransfield MT, Nahm MH, Han MK, Harnden S, Criner GJ, Martinez FJ, Scanlon PD, Woodruff PG, Washko GR, Connett JE, Anthonisen NR, Bailey WC. Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;180:499-505. 52. Dummer JF, Epton MJ, Cowan JO, Cook JM, Condliffe R, Landhuis CE, Smith AD, Taylor DR. Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide. Am J Respir Crit Care Med 2009;180:846-52. 53. Dunlay SM, Redfield MM, Weston SA, Therneau TM, Hall Long K, Shah ND, Roger VL. Hospitalizations after heart failure diagnosis a community perspective. J Am Coll Cardiol 2009;54:1695-702. 54. Effing T, Kerstjens H, van der Valk P, Zielhuis G, van der Palen J. (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study. Thorax 2009;64:956-62. 55. Eickmeier O, Huebner M, Herrmann E, Zissler U, Rosewich M, Baer PC, Buhl R, SchmittGrohe S, Zielen S, Schubert R. Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function. Cytokine;50:152-7. 56. Eisner MD, Blanc PD, Yelin EH, Katz PP, Sanchez G, Iribarren C, Omachi TA. Influence of anxiety on health outcomes in COPD. Thorax;65:229-34.

57. El-Attar M, Said M, El-Assal G, Sabry NA, Omar E, Ashour L. Serum trace element levels in COPD patient: the relation between trace element supplementation and period of mechanical ventilation in a randomized controlled trial. Respirology 2009;14:1180-7. 58. Fabbri LM, Calverley PM, Izquierdo-Alonso JL, Bundschuh DS, Brose M, Martinez FJ, Rabe KF. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet 2009;374:695-703. 59. Faganello MM, Tanni SE, Sanchez FF, Pelegrino NR, Lucheta PA, Godoy I. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease. Am J Med Sci;339:10-4. 60. Feldman G, Siler T, Prasad N, Jack D, Piggott S, Owen R, Higgins M, Kramer B. Efficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week study. BMC Pulm Med;10:11. 61. Felix JH, Cortez PC, Costa RC, Fortaleza SC, Pereira ED, Holanda MA. Computer-assisted evaluation of pulmonary emphysema in CT scans: comparison between a locally developed system and a freeware system. J Bras Pneumol 2009;35:868-76. 62. Ferguson GT, Calverley PM, Anderson JA, Jenkins CR, Jones PW, Willits LR, Yates JC, Vestbo J, Celli B. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest 2009;136:1456-65. 63. Fernandez AM, Pascual J, Ferrando C, Arnal A, Vergara I, Sevila V. Home-based pulmonary rehabilitation in very severe COPD: is it safe and useful? J Cardiopulm Rehabil Prev 2009;29:325-31. 64. Field SK, Conley DP, Thawer AM, Leigh R, Cowie RL. Effect of the management of patients with chronic cough by pulmonologists and certified respiratory educators on quality of life: a randomized trial. Chest 2009;136:1021-8. 65. Fischer MJ, Scharloo M, Abbink JJ, van 't Hul AJ, van Ranst D, Rudolphus A, Weinman J, Rabe KF, Kaptein AA. Drop-out and attendance in pulmonary rehabilitation: the role of clinical and psychosocial variables. Respir Med 2009;103:1564-71. 66. Ford PA, Durham AL, Russell RE, Gordon F, Adcock IM, Barnes PJ. Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD. Chest;137:1338-44. 67. Funk GC, Anders S, Breyer MK, Burghuber OC, Edelmann G, Heindl W, Hinterholzer G, Kohansal R, Schuster R, Schwarzmaier-D'Assie A, Valentin A, Hartl S. Incidence and outcome of weaning from mechanical ventilation according to new categories. Eur Respir J;35:88-94. 68. Furlanetto KC, Bisca GW, Oldemberg N, Sant'anna TJ, Morakami FK, Camillo CA, Cavalheri V, Hernandes NA, Probst VS, Ramos EM, Brunetto AF, Pitta F. Step counting and energy expenditure estimation in patients with chronic obstructive pulmonary disease and healthy elderly: accuracy of 2 motion sensors. Arch Phys Med Rehabil;91:261-7. 69. Gagnon P, Saey D, Vivodtzev I, Laviolette L, Mainguy V, Milot J, Provencher S, Maltais F. Impact of preinduced quadriceps fatigue on exercise response in chronic obstructive pulmonary disease and healthy subjects. J Appl Physiol 2009;107:832-40. 70. Gao Y, Goldstein AM, Consonni D, Pesatori AC, Wacholder S, Tucker MA, Caporaso NE, Goldin L, Landi MT. Family history of cancer and nonmalignant lung diseases as risk factors for lung cancer. Int J Cancer 2009;125:146-52. 71. Garcia-Rio F, Lores V, Mediano O, Rojo B, Hernanz A, Lopez-Collazo E, Alvarez-Sala R. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009;180:506-12.

72. Gardiner C, Gott M, Small N, Payne S, Seamark D, Barnes S, Halpin D, Ruse C. Living with advanced chronic obstructive pulmonary disease: patients concerns regarding death and dying. Palliat Med 2009;23:691-7. 73. Gelb AF, Flynn Taylor C, Krishnan A, Fraser C, Shinar CM, Schein MJ, Osann K. Central and peripheral airway sites of nitric oxide gas exchange in COPD. Chest;137:575-84. 74. Giardino ND, Curtis JL, Andrei AC, Fan VS, Benditt JO, Lyubkin M, Naunheim K, Criner G, Make B, Wise RA, Murray SK, Fishman AP, Sciurba FC, Liberzon I, Martinez FJ. Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study. Respir Res;11:29. 75. Gorlitzer M, Folkmann S, Meinhart J, Poslussny P, Thalmann M, Weiss G, Bijak M, Grabenwoeger M. A newly designed thorax support vest prevents sternum instability after median sternotomy. Eur J Cardiothorac Surg 2009;36:335-9; discussion 339. 76. Graat-Verboom L, Wouters EF, Smeenk FW, van den Borne BE, Lunde R, Spruit MA. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J 2009;34:209-18. 77. Grydeland TB, Dirksen A, Coxson HO, Pillai SG, Sharma S, Eide GE, Gulsvik A, Bakke PS. Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. Eur Respir J 2009;34:858-65. 78. Guarnieri G, Ferrazzoni S, Scarpa MC, Lalli A, Maestrelli P. Effects of inhalation of thermal water on exhaled breath condensate in chronic obstructive pulmonary disease. Respiration;79:216-21. 79. Hadi HA, Zubaid M, Al Mahmeed W, El-Menyar AA, Ridha M, Alsheikh-Ali AA, Singh R, Assad N, Al Habib K, Al Suwaidi J. Prevalence and prognosis of chronic obstructive pulmonary disease among 8167 Middle Eastern patients with acute coronary syndrome. Clin Cardiol;33:228-35. 80. Haider T, Casucci G, Linser T, Faulhaber M, Gatterer H, Ott G, Linser A, Ehrenbourg I, Tkatchouk E, Burtscher M, Bernardi L. Interval hypoxic training improves autonomic cardiovascular and respiratory control in patients with mild chronic obstructive pulmonary disease. J Hypertens 2009;27:1648-54. 81. Hanai N, Terada A, Ozawa T, Hirakawa H, Yokoi H, Hasegawa Y. [A Phase II study of docetaxel and cisplatin in patients with recurrent or unresectable squamous cell carcinoma of the head and neck]. Gan To Kagaku Ryoho 2009;36:1281-5. 82. Hilleman DE, Malesker MA, Morrow LE, Schuller D. A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD. Int J Chron Obstruct Pulmon Dis 2009;4:253-63. 83. Holland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, McDonald CF. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil;91:221-5. 84. Holm KE, Bowler RP, Make BJ, Wamboldt FS. Family relationship quality is associated with psychological distress, dyspnea, and quality of life in COPD. COPD 2009;6:359-68. 85. Hoogendoorn M, van Wetering CR, Schols AM, Rutten-van Molken MP. Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective? Eur Respir J;35:79-87. 86. Hsia D, Casaburi R, Pradhan A, Torres E, Porszasz J. Physiological responses to linear treadmill and cycle ergometer exercise in COPD. Eur Respir J 2009;34:605-15.

87. Hu XR, Han SX, Wang T, Zhang MK, Chen L, Wen FQ. [Association between interleukin-8 in lung tissues and stages of chronic obstructive pulmonary diseases]. Sichuan Da Xue Xue Bao Yi Xue Ban 2009;40:885-8. 88. Huang YJ, Kim E, Cox MJ, Brodie EL, Brown R, Wiener-Kronish JP, Lynch SV. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS;14:9-59. 89. Hunninghake GM, Cho MH, Tesfaigzi Y, Soto-Quiros ME, Avila L, Lasky-Su J, Stidley C, Melen E, Soderhall C, Hallberg J, Kull I, Kere J, Svartengren M, Pershagen G, Wickman M, Lange C, Demeo DL, Hersh CP, Klanderman BJ, Raby BA, Sparrow D, Shapiro SD, Silverman EK, Litonjua AA, Weiss ST, Celedon JC. MMP12, lung function, and COPD in high-risk populations. N Engl J Med 2009;361:2599-608. 90. Ichiwata T, Sasao G, Abe T, Kikuchi K, Koyama K, Fujiwara H, Nagai A, Kuwahira I, Nagao K. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in healthy subjects and patients with COPD. Adv Exp Med Biol;662:537-43. 91. Iversen M, Nilsson F, Sipponen J, Eiskjaer H, Mared L, Bergan S, Nystrom U, Fagertun HE, Solbu D, Simonsen S. Cyclosporine C2 levels have impact on incidence of rejection in de novo lung but not heart transplant recipients: the NOCTURNE study. J Heart Lung Transplant 2009;28:919-26. 92. Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial. J Am Coll Cardiol;55:1780-7. 93. Jansat JM, Lamarca R, de Miquel G, Schrodter A, Miletzki B, Gurniak M. Safety and pharmacokinetics of multiple doses of aclidinium bromide, a novel long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease, in healthy participants. J Clin Pharmacol 2009;49:1239-46. 94. Jansat JM, Lamarca R, Garcia Gil E, Ferrer P. Safety and pharmacokinetics of single doses of aclidinium bromide, a novel long-acting, inhaled antimuscarinic, in healthy subjects. Int J Clin Pharmacol Ther 2009;47:460-8. 95. Jogi J, Jonson B, Ekberg M, Bajc M. Ventilation-perfusion SPECT with 99mTc-DTPA versus Technegas: a head-to-head study in obstructive and nonobstructive disease. J Nucl Med;51:735-41. 96. Johansson LA, Bjorkenstam C, Westerling R. Unexplained differences between hospital and mortality data indicated mistakes in death certification: an investigation of 1,094 deaths in Sweden during 1995. J Clin Epidemiol 2009;62:1202-9. 97. Jones P, Harding G, Wiklund I, Berry P, Leidy N. Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J 2009;18:20815. 98. Jonkers CC, Lamers F, Evers SM, Bosma H, Metsemakers JF, Van Eijk JT. Economic evaluation of a minimal psychological intervention in chronically ill elderly patients with minor or mild to moderate depression: a randomized trial (the DELTA-study). Int J Technol Assess Health Care 2009;25:497-504. 99. Jungblut SA, Frickmann H, Zimmermann B, Muller U, Bargon J. [The effects of physical training on the body composition of patients with COPD]. Pneumologie 2009;63:374-9.

100. Jurjevic M, Matic I, Sakic-Zdravcevic K, Sakic S, Danic D, Bukovic D. Mechanical ventilation in chronic obstructive pulmonary disease patients, noninvasive vs. invasive method (randomized prospective study). Coll Antropol 2009;33:791-7. 101. Kaczmarek P, Sladek K, Skucha W, Rzeszutko M, Iwaniec T, Dziedzina S, Szczeklik A. The influence of simvastatin on selected inflammatory markers in patients with chronic obstructive pulmonary disease. Pol Arch Med Wewn;120:11-7. 102. Kanda S, Fujimoto K, Komatsu Y, Yasuo M, Hanaoka M, Kubo K. Evaluation of respiratory impedance in asthma and COPD by an impulse oscillation system. Intern Med;49:2330. 103. Kapoor R, Muruganandham K, Gulia AK, Singla M, Agrawal S, Mandhani A, Ansari MS, Srivastava A. Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis. BJU Int;105:986-9. 104. Kim SH, Kwak HJ, Kim TB, Chang YS, Jeong JW, Kim CW, Yoon HJ, Jee YK. Inappropriate techniques used by internal medicine residents with three kinds of inhalers (a metered dose inhaler, Diskus, and Turbuhaler): changes after a single teaching session. J Asthma 2009;46:944-50. 105. Koczulla R, Dragonieri S, Schot R, Bals R, Gauw SA, Vogelmeier C, Rabe KF, Sterk PJ, Hiemstra PS. Comparison of exhaled breath condensate pH using two commercially available devices in healthy controls, asthma and COPD patients. Respir Res 2009;10:78. 106. Kotz D, Vos R, Huibers MJ. Ethical analysis of the justifiability of labelling with COPD for smoking cessation. J Med Ethics 2009;35:534-40. 107. Kuempel ED, Wheeler MW, Smith RJ, Vallyathan V, Green FH. Contributions of dust exposure and cigarette smoking to emphysema severity in coal miners in the United States. Am J Respir Crit Care Med 2009;180:257-64. 108. Lam KB, Jiang CQ, Jordan RE, Miller MR, Zhang WS, Cheng KK, Lam TH, Adab P. Prior TB, smoking, and airflow obstruction: a cross-sectional analysis of the Guangzhou Biobank Cohort Study. Chest;137:593-600. 109. Lapperre TS, Snoeck-Stroband JB, Gosman MM, Jansen DF, van Schadewijk A, Thiadens HA, Vonk JM, Boezen HM, Ten Hacken NH, Sont JK, Rabe KF, Kerstjens HA, Hiemstra PS, Timens W, Postma DS, Sterk PJ. Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2009;151:517-27. 110. Laveneziana P, Palange P, Ora J, Martolini D, O'Donnell DE. Bronchodilator effect on ventilatory, pulmonary gas exchange, and heart rate kinetics during high-intensity exercise in COPD. Eur J Appl Physiol 2009;107:633-43. 111. Laviolette L, O'Donnell DE, Webb KA, Hamilton AL, Kesten S, Maltais F. Performance during constant workrate cycling exercise in women with COPD and hyperinflation. COPD 2009;6:340-51. 112. Ley-Zaporozhan J, Ley S, Eberhardt R, Kauczor HU, Heussel CP. Visualization of morphological parenchymal changes in emphysema: comparison of different MRI sequences to 3D-HRCT. Eur J Radiol;73:43-9. 113. Liddell F, Webber J. Pulmonary rehabilitation for chronic obstructive pulmonary disease: a pilot study evaluating a once-weekly versus twice-weekly supervised programme. Physiotherapy;96:68-74. 114. Liu DS, Li XO, Ying BW, Chen L, Wang T, Xu D, Wen FQ. Effects of single nucleotide polymorphisms 869 T/C and 915 G/C in the exon 1 locus of transforming growth factor-beta1

gene on chronic obstructive pulmonary disease susceptibility in Chinese. Chin Med J (Engl);123:390-4. 115. Lovasi GS, Diez Roux AV, Hoffman EA, Kawut SM, Jacobs DR, Jr., Barr RG. Association of environmental tobacco smoke exposure in childhood with early emphysema in adulthood among nonsmokers: the MESA-lung study. Am J Epidemiol;171:54-62. 116. Lusuardi M, Blasi F, Terzano C, Cricelli C, Crispino N, Comarella L, De Benedetto F, Sanguinetti CM, Allegra L, Donner CF. Standards of care and clinical predictors in patients hospitalised for a COPD exacerbation--the Italian SOS (Stratification Observational Study). Monaldi Arch Chest Dis 2009;71:153-60. 117. Maggi S, Siviero P, Gonnelli S, Schiraldi C, Malavolta N, Nuti R, Crepaldi G. Osteoporosis risk in patients with chronic obstructive pulmonary disease: the EOLO study. J Clin Densitom 2009;12:345-52. 118. Maggiore SM, Richard JC, Abroug F, Diehl JL, Antonelli M, Sauder P, Mancebo J, Ferrer M, Lellouche F, Lecourt L, Beduneau G, Brochard L. A multicenter, randomized trial of noninvasive ventilation with helium-oxygen mixture in exacerbations of chronic obstructive lung disease. Crit Care Med;38:145-51. 119. Magnussen H, Watz H, Zimmermann I, Macht S, Greguletz R, Falques M, Jarreta D, Garcia Gil E. Peak inspiratory flow through the Genuair inhaler in patients with moderate or severe COPD. Respir Med 2009;103:1832-7. 120. Man MA, Bondor C, Pop M, Rajnoveanu R, Alexandrescu D, Rusu G. [Why do doctors smoke?]. Pneumologia 2009;58:195-200. 121. Matsuoka S, Washko GR, Dransfield MT, Yamashiro T, San Jose Estepar R, Diaz A, Silverman EK, Patz S, Hatabu H. Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitation. Acad Radiol;17:93-9. 122. Matsuoka S, Washko GR, Yamashiro T, Estepar RS, Diaz A, Silverman EK, Hoffman E, Fessler HE, Criner GJ, Marchetti N, Scharf SM, Martinez FJ, Reilly JJ, Hatabu H. Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema. Am J Respir Crit Care Med;181:218-25. 123. McEvoy RD, Pierce RJ, Hillman D, Esterman A, Ellis EE, Catcheside PG, O'Donoghue FJ, Barnes DJ, Grunstein RR. Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax 2009;64:561-6. 124. Mintz M, Gilsenan AW, Bui CL, Ziemiecki R, Stanford RH, Lincourt W, Ortega H. Assessment of asthma control in primary care. Curr Med Res Opin 2009;25:2523-31. 125. Miravitlles M, Anzueto A, Ewig S, Legnani D, Stauch K. Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study. Ther Adv Respir Dis 2009;3:26777. 126. Miravitlles M, Marin A, Monso E, Vila S, de la Roza C, Hervas R, Esquinas C, Garcia M, Millares L, Morera J, Torres A. Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD. Eur Respir J 2009;34:1066-71. 127. Miravitlles M, Soriano JB, Garcia-Rio F, Munoz L, Duran-Tauleria E, Sanchez G, Sobradillo V, Ancochea J. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009;64:863-8. 128. Moullec G, Ninot G. An integrated programme after pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: effect on emotional and functional dimensions of quality of life. Clin Rehabil;24:122-36.

129. Mularski RA, Munjas BA, Lorenz KA, Sun S, Robertson SJ, Schmelzer W, Kim AC, Shekelle PG. Randomized controlled trial of mindfulness-based therapy for dyspnea in chronic obstructive lung disease. J Altern Complement Med 2009;15:1083-90. 130. Nguyen HQ, Gill DP, Wolpin S, Steele BG, Benditt JO. Pilot study of a cell phone-based exercise persistence intervention post-rehabilitation for COPD. Int J Chron Obstruct Pulmon Dis 2009;4:301-13. 131. Niewoehner DE, Lapidus R, Cote C, Sharafkhaneh A, Plautz M, Johnson P, Kesten S. Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease. Pulm Pharmacol Ther 2009;22:587-92. 132. Nizet TA, Heijdra YF, van den Elshout FJ, van de Ven MJ, Bosch FH, Mulder PH, Folgering HT. Respiratory muscle strength and muscle endurance are not affected by acute metabolic acidemia. Clin Physiol Funct Imaging 2009;29:392-9. 133. O'Donnell DE, Travers J, Webb KA, He Z, Lam YM, Hamilton A, Kesten S, Maltais F, Magnussen H. Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD. Eur Respir J 2009;34:866-74. 134. Ohbayashi H, Shibata N, Hirose T, Adachi M. Additional effects of pranlukast in salmeterol/fluticasone combination therapy for the asthmatic distal airway in a randomized crossover study. Pulm Pharmacol Ther 2009;22:574-9. 135. O'Shea SD, Taylor NF, Paratz JD. Progressive resistance exercise improves muscle strength and may improve elements of performance of daily activities for people with COPD: a systematic review. Chest 2009;136:1269-83. 136. Osterlund Efraimsson E, Klang B, Larsson K, Ehrenberg A, Fossum B. Communication and self-management education at nurse-led COPD clinics in primary health care. Patient Educ Couns 2009;77:209-17. 137. Palwai A, Skowronski M, Coreno A, Drummond C, McFadden ER, Jr. Critical comparisons of the clinical performance of oxygen-conserving devices. Am J Respir Crit Care Med;181:106171. 138. Panettieri RA, Jr., MacIntyre N, Sims M, Kerwin E, Fogarty C, Noonan M, Claus R, Andrews WT. Comparison of the efficacy and safety of arformoterol 15 microg twice daily and arformoterol 30 microg once daily in COPD: a single-dose, multicenter, randomized, modifiedblind, two-way crossover study. Clin Ther 2009;31:1716-23. 139. Parr DG, Dirksen A, Piitulainen E, Deng C, Wencker M, Stockley RA. Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency. Respir Res 2009;10:75. 140. Partridge MR, Schuermann W, Beckman O, Persson T, Polanowski T. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. Ther Adv Respir Dis 2009;3:1-11. 141. Patel SN, Tsai CL, Boudreaux ED, Kilgannon JH, Sullivan AF, Blumenthal D, Camargo CA, Jr. Multicenter study of cigarette smoking among patients presenting to the emergency department with acute asthma. Ann Allergy Asthma Immunol 2009;103:121-7. 142. Pellicer Ciscar C, Soler Cataluna JJ, Andreu Rodriguez AL, Bueso Fabra J. Diagnosis of COPD in hospitalised patients. Arch Bronconeumol;46:64-9. 143. Perrault H, Baril J, Henophy S, Rycroft A, Bourbeau J, Maltais F. Paced-walk and step tests to assess exertional dyspnea in COPD. COPD 2009;6:330-9.

144. Pilgram TK, Quirk JD, Bierhals AJ, Yusen RD, Lefrak SS, Cooper JD, Gierada DS. Accuracy of emphysema quantification performed with reduced numbers of CT sections. AJR Am J Roentgenol;194:585-91. 145. Price D, Crockett A, Arne M, Garbe B, Jones RC, Kaplan A, Langhammer A, Williams S, Yawn BP. Spirometry in primary care case-identification, diagnosis and management of COPD. Prim Care Respir J 2009;18:216-23. 146. Probst-Hensch NM, Curjuric I, Pierre-Olivier B, Ackermann-Liebrich U, Bettschart RW, Brandli O, Brutsche M, Burdet L, Gerbase MW, Knopfli B, Kunzli N, Pons MG, Schindler C, Tschopp JM, Rochat T, Russi EW. Longitudinal change of prebronchodilator spirometric obstruction and health outcomes: results from the SAPALDIA cohort. Thorax;65:150-6. 147. Quinet P, Young CA, Heritier F. The use of dry powder inhaler devices by elderly patients suffering from chronic obstructive pulmonary disease. Ann Phys Rehabil Med;53:69-76. 148. Rakhimova E, Wiehlmann L, Brauer AL, Sethi S, Murphy TF, Tummler B. Pseudomonas aeruginosa population biology in chronic obstructive pulmonary disease. J Infect Dis 2009;200:1928-35. 149. Rastan AJ, Walther T, Falk V, Kempfert J, Merk D, Lehmann S, Holzhey D, Mohr FW. Does reasonable incomplete surgical revascularization affect early or long-term survival in patients with multivessel coronary artery disease receiving left internal mammary artery bypass to left anterior descending artery? Circulation 2009;120:S70-7. 150. Raurich JM, Rialp G, Ibanez J, Ayestaran I, Llompart-Pou JA, Togores B. Hypercapnia test and weaning outcome from mechanical ventilation in COPD patients. Anaesth Intensive Care 2009;37:726-32. 151. Reece AS. Chronic toxicology of cannabis. Clin Toxicol (Phila) 2009;47:517-24. 152. Rena O, Papalia E, Mineo TC, Massera F, Pirondini E, Turello D, Casadio C. Air-leak management after upper lobectomy in patients with fused fissure and chronic obstructive pulmonary disease: a pilot trial comparing sealant and standard treatment. Interact Cardiovasc Thorac Surg 2009;9:973-7. 153. Renvall MJ, Friedman P, Ramsdell JW. Predictors of body mass index in patients with moderate to severe emphysema. COPD 2009;6:432-6. 154. Riario-Sforza GG, Incorvaia C, Paterniti F, Pessina L, Caligiuri R, Pravettoni C, Di Marco F, Centanni S. Effects of pulmonary rehabilitation on exercise capacity in patients with COPD: a number needed to treat study. Int J Chron Obstruct Pulmon Dis 2009;4:315-9. 155. Ringbaek T, Brondum E, Martinez G, Thogersen J, Lange P. Long-term effects of 1-year maintenance training on physical functioning and health status in patients with COPD: A randomized controlled study. J Cardiopulm Rehabil Prev;30:47-52. 156. Roche N, Perez T, Martinat Y, Huas D, Serrier P, Pribil C, Chanal I, Huchon G. [Difficulties in the assessment of dyspnea and respiratory function in general practice]. Presse Med 2009;38:1041-8. 157. Samolski D, Tarrega J, Anton A, Mayos M, Marti S, Farrero E, Guell R. Sleep hypoventilation due to increased nocturnal oxygen flow in hypercapnic COPD patients. Respirology;15:283-8. 158. Sanz F, Restrepo MI, Fernandez E, Briones ML, Blanquer R, Mortensen EM, Chiner E, Blanquer J. Is it possible to predict which patients with mild pneumonias will develop hypoxemia? Respir Med 2009;103:1871-7. 159. Sasaki T, Nakayama K, Yasuda H, Yoshida M, Asamura T, Ohrui T, Arai H, Araya J, Kuwano K, Yamaya M. A randomized, single-blind study of lansoprazole for the prevention of

exacerbations of chronic obstructive pulmonary disease in older patients. J Am Geriatr Soc 2009;57:1453-7. 160. Satoh H, Iwashima A, Endo Y, Nakayama H, Hasegawa T, Suzuki E. [Effect of proactive use of inhaled procaterol on dyspnea in daily activities and quality of life in patients with chronic obstructive pulmonary disease]. Nihon Kokyuki Gakkai Zasshi 2009;47:772-80. 161. Schembri S, Morant S, Winter JH, MacDonald TM. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD. Thorax 2009;64:567-72. 162. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, Neidert S, Fricker T, Blum C, Schild U, Regez K, Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Mueller B. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. Jama 2009;302:1059-66. 163. Sedeno MF, Nault D, Hamd DH, Bourbeau J. A self-management education program including an action plan for acute COPD exacerbations. COPD 2009;6:352-8. 164. Sellares J, Acerbi I, Loureiro H, Dellaca RL, Ferrer M, Torres A, Navajas D, Farre R. Respiratory impedance during weaning from mechanical ventilation in a mixed population of critically ill patients. Br J Anaesth 2009;103:828-32. 165. Sethi S, Jones PW, Theron MS, Miravitlles M, Rubinstein E, Wedzicha JA, Wilson R. Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Respir Res;11:10. 166. Shadmehr MB, Arab M, Pejhan S, Daneshvar A, Javaherzadeh N, Abbasi A, Ahmadi ZH, Radpay B, Dabir S, Parsa T, Mohammadi F, Mansoori SD, Tabarsi P, Amiri MV, Marjani M, Kashani BS, Najafizadeh K, Shafaghi S, Ghorbani F, Masjedi MR, Velayati AA. Eight years of lung transplantation: experience of the National Research Institute of Tuberculosis and Lung Diseases. Transplant Proc 2009;41:2887-9. 167. Shaykhiev R, Krause A, Salit J, Strulovici-Barel Y, Harvey BG, O'Connor TP, Crystal RG. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol 2009;183:2867-83. 168. Siedlinski M, Boezen HM, Boer JM, Smit HA, Postma DS. ABCC1 polymorphisms contribute to level and decline of lung function in two population-based cohorts. Pharmacogenet Genomics 2009;19:675-84. 169. Simoni-Wastila L, Yang HW, Blanchette CM, Zhao L, Qian J, Dalal AA. Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population. Curr Med Res Opin 2009;25:2729-35. 170. Singh D, Smyth L, Borrill Z, Sweeney L, Tal-Singer R. A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients. J Clin Pharmacol;50:94-100. 171. Singh JA. Accuracy of Veterans Affairs databases for diagnoses of chronic diseases. Prev Chronic Dis 2009;6:A126. 172. Sleszycka J, Wozniak K, Banaszek M, Wiechno W, Domagala-Kulawik J. [Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease]. Pol Merkur Lekarski 2009;27:92-6. 173. Spahija J, de Marchie M, Albert M, Bellemare P, Delisle S, Beck J, Sinderby C. Patientventilator interaction during pressure support ventilation and neurally adjusted ventilatory assist. Crit Care Med;38:518-26.

174. Stav D, Raz M. Effect of N-acetylcysteine on air trapping in COPD: a randomized placebocontrolled study. Chest 2009;136:381-6. 175. Sterman DH, Mehta AC, Wood DE, Mathur PN, McKenna RJ, Jr., Ost DE, Truwit JD, Diaz P, Wahidi MM, Cerfolio R, Maxfield R, Musani AI, Gildea T, Sheski F, Machuzak M, Haas AR, Gonzalez HX, Springmeyer SC. A multicenter pilot study of a bronchial valve for the treatment of severe emphysema. Respiration;79:222-33. 176. Storre JH, Bohm P, Dreher M, Windisch W. Clinical impact of leak compensation during non-invasive ventilation. Respir Med 2009;103:1477-83. 177. Sundblad BM, Larsson K, Nathell L. Lung function testing influences the attitude toward smoking cessation. Nicotine Tob Res;12:37-42. 178. Svanes C, Sunyer J, Plana E, Dharmage S, Heinrich J, Jarvis D, de Marco R, Norback D, Raherison C, Villani S, Wjst M, Svanes K, Anto JM. Early life origins of chronic obstructive pulmonary disease. Thorax;65:14-20. 179. Sverzellati N, Ingegnoli A, Calabro E, Randi G, La Vecchia C, Marchiano A, Kuhnigk JM, Hansell DM, Zompatori M, Pastorino U. Bronchial diverticula in smokers on thin-section CT. Eur Radiol;20:88-94. 180. Tandon MK, Phillips M, Waterer G, Dunkley M, Comans P, Clancy R. Oral immunotherapy with inactivated nontypeable Haemophilus influenzae reduces severity of acute exacerbations in severe COPD. Chest;137:805-11. 181. Terada K, Muro S, Ohara T, Haruna A, Marumo S, Kudo M, Ogawa E, Hoshino Y, Hirai T, Niimi A, Mishima M. Cough-reflex sensitivity to inhaled capsaicin in COPD associated with increased exacerbation frequency. Respirology 2009;14:1151-5. 182. Terziyski K, Marinov B, Hodgev V, Tokmakova M, Kostianev S. Standardized peak exercise perception score: validation of a new index of effort perception. J Cardiopulm Rehabil Prev;30:40-6. 183. Trappenburg JC, Koevoets L, de Weert-van Oene GH, Monninkhof EM, Bourbeau J, Troosters T, Verheij TJ, Lammers JW, Schrijvers AJ. Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCT. BMC Pulm Med 2009;9:52. 184. Troosters T, Probst VS, Crul T, Pitta F, Gayan-Ramirez G, Decramer M, Gosselink R. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med;181:1072-7. 185. Tsai CL, Rowe BH, Cydulka RK, Camargo CA, Jr. ED visit volume and quality of care in acute exacerbations of chronic obstructive pulmonary disease. Am J Emerg Med 2009;27:1040-9. 186. Tsuboi T, Oga T, Machida K, Chihara Y, Matsumoto H, Niimi A, Sumi K, Ohi M, Mishima M, Chin K. Importance of ventilator mode in long-term noninvasive positive pressure ventilation. Respir Med 2009;103:1854-61. 187. Ueda K, Tanaka T, Hayashi M, Hamano K. Role of inhaled tiotropium on the perioperative outcomes of patients with lung cancer and chronic obstructive pulmonary disease. Thorac Cardiovasc Surg;58:38-42. 188. Undas A, Kaczmarek P, Sladek K, Stepien E, Skucha W, Rzeszutko M, Gorkiewicz-Kot I, Tracz W. Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment. Thromb Haemost 2009;102:1176-82. 189. Valero C, Monteagudo M, Llagostera M, Bayona X, Granollers S, Acedo M, Ferro JJ, Rodriguez-Latre L, Almeda J, Munoz L. Evaluation of a combined strategy directed towards health-care professionals and patients with chronic obstructive pulmonary disease (COPD):

information and health education feedback for improving clinical monitoring and quality-of-life. BMC Public Health 2009;9:442. 190. van Beek EJ, Dahmen AM, Stavngaard T, Gast KK, Heussel CP, Krummenauer F, Schmiedeskamp J, Wild JM, Sogaard LV, Morbach AE, Schreiber LM, Kauczor HU. Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial. Eur Respir J 2009;34:1311-21. 191. van den Bemt L, Schermer TR, Smeele IJ, Boonman-de Winter LJ, van Boxem T, Denis J, Grootens-Stekelenburg JG, Grol RP, van Weel C. An expert-supported monitoring system for patients with chronic obstructive pulmonary disease in general practice: results of a cluster randomised controlled trial. Med J Aust 2009;191:249-54. 192. van der Lee I, Gietema HA, Zanen P, van Klaveren RJ, Prokop M, Lammers JW, van den Bosch JM. Nitric oxide diffusing capacity versus spirometry in the early diagnosis of emphysema in smokers. Respir Med 2009;103:1892-7. 193. Van Schayck CP, Kaper J, Wagena EJ, Wouters EF, Severens JL. The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients. Addiction 2009;104:2110-7. 194. van Wetering CR, Hoogendoorn M, Broekhuizen R, Geraerts-Keeris GJ, De Munck DR, Rutten-van Molken MP, Schols AM. Efficacy and costs of nutritional rehabilitation in musclewasted patients with chronic obstructive pulmonary disease in a community-based setting: a prespecified subgroup analysis of the INTERCOM trial. J Am Med Dir Assoc;11:179-87. 195. van Wetering CR, Hoogendoorn M, Mol SJ, Rutten-van Molken MP, Schols AM. Shortand long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial. Thorax;65:7-13. 196. Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, Knobil K, Willits LR, Yates JC, Jones PW. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 2009;64:939-43. 197. Vollmer WM, Gislason T, Burney P, Enright PL, Gulsvik A, Kocabas A, Buist AS. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 2009;34:588-97. 198. Waterhouse JC, Walters SJ, Oluboyede Y, Lawson RA. A randomised 2 x 2 trial of community versus hospital pulmonary rehabilitation, followed by telephone or conventional follow-up. Health Technol Assess;14:i-v, vii-xi, 1-140. 199. Weatherall M, Travers J, Shirtcliffe PM, Marsh SE, Williams MV, Nowitz MR, Aldington S, Beasley R. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J 2009;34:812-8. 200. Welte T, Miravitlles M, Hernandez P, Eriksson G, Peterson S, Polanowski T, Kessler R. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;180:741-50. 201. Woodruff PG, Wolff M, Hohlfeld JM, Krug N, Dransfield MT, Sutherland ER, Criner GJ, Kim V, Prasse A, Nivens MC, Tetzlaff K, Heilker R, Fahy JV. Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease. Am J Respir Crit Care Med;181:438-45. 202. Worth H, Schacher C, Dethlefsen U. Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: a placebo-controlled double-blind trial. Respir Res 2009;10:69.

203. Yawn B, Mannino D, Littlejohn T, Ruoff G, Emmett A, Raphiou I, Crater G. Prevalence of COPD among symptomatic patients in a primary care setting. Curr Med Res Opin 2009;25:26717. 204. Young RP, Hopkins RJ, Hay BA, Epton MJ, Mills GD, Black PN, Gardner HD, Sullivan R, Gamble GD. A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers. Postgrad Med J 2009;85:515-24. 205. Zhang J, Xu JF, Liu YB, Xiao ZK, Huang JA, Si B, Sun SH, Xia QM, Wu XJ, Cao GY, Shi YG, Zhang YY. Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China. J Infect Chemother 2009;15:293-300.